Prof. Johann de Bono advises Peptone on clinical oncology and collaborates with the company on AR-NTD disease biology and mechanism of action. Regius Professor of Cancer Research at The Institute of Cancer Research and The Royal Marsden, he directs early phase drug development and leads research in prostate cancer, circulating biomarkers, and molecularly stratified clinical trials.
Scientific Advisor for Clinical Oncology